SARSYS (SARS) Q1 2025 earnings summary

Executive summary

• Net sales increased slightly to 8.4 MSEK in Q1 2025 from 7.9 MSEK year-over-year, but profitability declined due to negative inventory revaluations and high personnel costs.

• Order intake dropped sharply to 0.8 MSEK from 20 MSEK in Q1 2024, reflecting subdued market activity and volatility.

• Efficiency program and cost discipline measures are ongoing to restore profitability and strengthen the financial position.

• A rights issue was completed, raising 10.3 MSEK before costs, providing some financial flexibility.

Financial highlights

• Operating loss widened to -5.5 MSEK from -3.1 MSEK year-over-year; net loss after financial items was -5.9 MSEK versus -3.3 MSEK.

• Gross margin fell to 36% from 53% year-over-year.

• Earnings per share improved to -0.17 SEK from -0.27 SEK year-over-year due to increased share count.

• Cash and cash equivalents at period end were 10.6 MSEK, up from 4.7 MSEK year-over-year.

• Equity per share was -0.05 SEK, down from 0.5 SEK year-over-year; equity ratio at -3% versus 12% year-over-year.

Outlook and guidance

• Management continues to focus on cost control, operational efficiency, and initiatives to quickly improve cash flow.

• Ongoing optimization of the operating model to adapt to current market conditions and strengthen competitiveness.